Semi-Solid Dosage CDMO Market Size, Share & Trends Report

Semi-Solid Dosage CDMO Market (2025 - 2030) Size, Share & Trends Analysis Report By Route of Administration (Topical, Transdermal), By Product, By Service, By End Use, By Region, And Segment Forecasts

Market Segmentation

Semi-Solid Dosage CDMO Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Topical
- Transdermal
- Others
Semi-Solid Dosage CDMO Product Outlook (Revenue, USD Million, 2018 - 2030)
- Ointments
- Creams and Lotions
- Pastes
- Gels
- Others
Semi-Solid Dosage CDMO Service Outlook (Revenue, USD Million, 2018 - 2030)
- Contract Development
- Contract Manufacturing
Semi-Solid Dosage CDMO End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Others
Semi-Solid Dosage CDMO Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
    - Topical
    - Transdermal
    - Others
  - North America Product Outlook (Revenue in USD Million, 2018 - 2030)
    - Ointments
    - Creams and Lotions
    - Pastes
    - Gels
    - Others
  - North America Service Outlook (Revenue in USD Million, 2018 - 2030)
    - Contract Development
    - Contract Manufacturing
  - North America End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceutical Companies
    - Biopharmaceutical Companies
    - Others
  - U.S.
    - U.S. Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - U.S. Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - U.S. Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - U.S. End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - Canada
    - Canada Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - Canada Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - Canada Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - Canada End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - Mexico
    - Mexico Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - Mexico Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - Mexico Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - Mexico End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
- Europe
  - Europe Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
    - Topical
    - Transdermal
    - Others
  - Europe Product Outlook (Revenue in USD Million, 2018 - 2030)
    - Ointments
    - Creams and Lotions
    - Pastes
    - Gels
    - Others
  - Europe Service Outlook (Revenue in USD Million, 2018 - 2030)
    - Contract Development
    - Contract Manufacturing
  - Europe End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceutical Companies
    - Biopharmaceutical Companies
    - Others
  - UK
    - UK Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - UK Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - UK Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - UK End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - Germany
    - Germany Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - Germany Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - Germany Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - Germany End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - France
    - France Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - France Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - France Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - France End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - Italy
    - Italy Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - Italy Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - Italy Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - Italy End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - Spain
    - Spain Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - Spain Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - Spain Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - Spain End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - Sweden
    - Sweden Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - Sweden Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - Sweden Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - Sweden End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - Denmark
    - Denmark Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - Denmark Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - Denmark Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - Denmark End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - Norway
    - Norway Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - Norway Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - Norway Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - Norway End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
- Asia Pacific
  - Asia Pacific Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
    - Topical
    - Transdermal
    - Others
  - Asia Pacific Product Outlook (Revenue in USD Million, 2018 - 2030)
    - Ointments
    - Creams and Lotions
    - Pastes
    - Gels
    - Others
  - Asia Pacific Service Outlook (Revenue in USD Million, 2018 - 2030)
    - Contract Development
    - Contract Manufacturing
  - Asia Pacific End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceutical Companies
    - Biopharmaceutical Companies
    - Others
  - Japan
    - Japan Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - Japan Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - Japan Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - Japan End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - China
    - China Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - China Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - China Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - China End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - India
    - India Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - India Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - India Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - India End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - Thailand
    - Thailand Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - Thailand Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - Thailand Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - Thailand End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - South Korea
    - South Korea Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - South Korea Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - South Korea Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - South Korea End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - Australia
    - Australia Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - Australia Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - Australia Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - Australia End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
- Latin America
  - Latin America Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
    - Topical
    - Transdermal
    - Others
  - Latin America Product Outlook (Revenue in USD Million, 2018 - 2030)
    - Ointments
    - Creams and Lotions
    - Pastes
    - Gels
    - Others
  - Latin America Service Outlook (Revenue in USD Million, 2018 - 2030)
    - Contract Development
    - Contract Manufacturing
  - Latin America End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceutical Companies
    - Biopharmaceutical Companies
    - Others
  - Brazil
    - Brazil Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - Brazil Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - Brazil Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - Brazil End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - Argentina
    - Argentina Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - Argentina Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - Argentina Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - Argentina End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
- Middle East & Africa
  - Middle East & Africa Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
    - Topical
    - Transdermal
    - Others
  - Middle East & Africa Product Outlook (Revenue in USD Million, 2018 - 2030)
    - Ointments
    - Creams and Lotions
    - Pastes
    - Gels
    - Others
  - Middle East & Africa Service Outlook (Revenue in USD Million, 2018 - 2030)
    - Contract Development
    - Contract Manufacturing
  - Middle East & Africa End Use Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceutical Companies
    - Biopharmaceutical Companies
    - Others
  - South Africa
    - South Africa Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - South Africa Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - South Africa Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - South Africa End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - Saudi Arabia
    - Saudi Arabia Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - Saudi Arabia Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - Saudi Arabia Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - Saudi Arabia End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - UAE
    - UAE Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - UAE Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - UAE Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - UAE End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others
  - Kuwait
    - Kuwait Route of Administration Outlook (Revenue in USD Million, 2018 - 2030)
      - Topical
      - Transdermal
      - Others
    - Kuwait Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Ointments
      - Creams and Lotions
      - Pastes
      - Gels
      - Others
    - Kuwait Service Outlook (Revenue in USD Million, 2018 - 2030)
      - Contract Development
      - Contract Manufacturing
    - Kuwait End Use Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical Companies
      - Biopharmaceutical Companies
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments